A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

For men with the return of prostate cancer, a novel combined treatment can potentially give them an extended period before ...

An international study reports that the combination of two drugs could significantly retard the development of a dangerous ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about managing side effects following prostate cancer treatment. While treatment ...

For patients with intermediate-risk, localized prostate cancer, radiation therapy delivered in five sessions reduced ...

The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...

Men with advanced prostate cancer undergoing local therapies such as radiation therapy or radical prostatectomy experience significantly more gastrointestinal and sexual issues, along with problems ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

This early stage is often detected through routine screenings, such as a prostate-specific antigen (PSA) blood test and a digital rectal exam (DRE), before any symptoms arise. Because the disease is ...

A shorter radiation course improved quality of life among men with intermediate-risk, localized prostate cancer, according to ...

Men with prostate cancer can safely exercise, benefiting from reduced treatment side effects, improved mental health, and ...

BAMF Health in Grand Rapids is offering an alternative treatment for prostate cancer that doesn't involve chemotherapy.